Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren

PHASE3CompletedINTERVENTIONAL
Enrollment

616

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy
Interventions
DRUG

Sulfadoxine-pyrimethamine

Tablets 500 mg sulfadoxine - 25 mg pyrimethamine will be given as single oral dose of ½ tablets per 10 kg of weigh: 1 tablet for weigh less than 20 kg, 1.5 tablets in 20-29 kg, and 2 tablets for children of weigh 30 or more

DRUG

Piperaquine

Piperaquine tablet 320 mg manufactured by Sigma Tau will be used at two treatment doses of 16-24 mg/kg at 24 hours intervals as follows: 1 tablets for weigh 15-19 kg, 1.5 tablets for 20-29 kg, and 2 tablets for 30-39 kg, and 2.5 tablets for 40 kg or more.

DRUG

Albendazole

One oral 200 mg will be given to children of 1-2 years and one oral dose of 400 mg to children older than 2 years. The treatment will be repeated at 4-months in the follow-up in accordance with the WHO guideline.

DRUG

Praziquantel

Praziquantel is a tremacide used for treatment of infections due to schistosomes. Praziquantel will be given as one dose of 40 mg/kg at enrolment and at 12 months follow up.

Trial Locations (1)

Unknown

Mokali health area of Biyela health zone, in Kinshasa province., Kinshasa

All Listed Sponsors
collaborator

Fund for Scientific Research, Flanders, Belgium

OTHER

collaborator

University of Kinshasa

OTHER

lead

Universiteit Antwerpen

OTHER

NCT01722539 - Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren | Biotech Hunter | Biotech Hunter